Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy and t-PA Treatment
Ann Neurol 29:210-213, Pendlebury,W.W.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991
Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990
Guillain-Barre Syndrome After Streptokinase Therapy
Acta Neurologica Scand 82:153, Roquer,J.,et al, 1990
Ancrod Causes Rapid Thrombolysis in Patients with Acute Stroke
Am J Med Sci 299:319-325, Polla,K.V.E.,et al, 1990
Multiple Microembolic after Disintegration of Clot During Thrombolysis for Acute Myocardial Infarction
BMJ 299:1310-1312, Stafford,P.J.,et al, 1989
Local Intra-Arterial Fibrinolytic Therapy in Acute Carotid Territory Stroke, A Pilot Study
Stroke 19:307-313, delZoppo,G.J.,et al, 1988
Thrombolytic Therapy:Current Status (Second of Two Parts)
NEJM 318:1585-1595, Marder,V.J.&Sherry,S., 1988
Intracarotid Urokinase with Thromboembolic Occlusion of the Middle Cerebral Artery
Stroke 19:802-812, Mori,E.,et al, 1988
Thrombolytic Therapy in Cerebrovascular Disease
Stroke 19:1174-1179, DelZoppo,G.J., 1988
Intra-arterial Thrombolytic Therapy Improves Outcome in Patients with Acute Vertebrobasilar Occlusive Disease
Stroke 19:1216-1222, Hacke,W.,et al, 1988
Fatal Ischaemic Brain Oedema after Early Thrombolysis with Tissue Plasminogen Activator in Acute Stroke
BMJ 297:1571-1574, Koudstaal,P.J.,et al, 1988
Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
Arch Neurol 45:1070-1073, Carlson,S.E.,et al, 1988
Use of Ancrod in Acute or Progressing Ischemic Cerebral Infarction
Ann Emerg Med 17:1208-1209, Olinger,C.P.,et al, 1988
Thrombolysis & Stroke, Past & Future
Arch Neurol 44:748-768, Sloan,M.A., 1987
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Cerebrovascular Complications of Streptokinase Infusion
JAMA 253:1777-1779, Aldrich,M.S.,et al, 1985
Controlled Trial of Ancrod in Ischemic Stroke
Arch Neurol 40:803-808, Hossman,V.,et al, 1983
MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,
Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
NEJM 391:1256-1258, Laugwitz,L.,et al, 2024
Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024
Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease:International MOGAD Panel Proposed Criteria
Lancet Neurol doi.org110.1016/51474-4422(22)00431-8, Banwell,B.,et al, 2023
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Clinical Features and Diagnosis
UptoDate.com, March, Flanagan,E.P. & Tillema,J-M, 2023
Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Lentiviral Haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
Lancet 399:372-383, Fumagalli, F.,et al, 2022
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
Ann Neurol 92:201-212, Lindgren, U.,et al, 2022
Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022
A 23-Year-Old Woman Presenting with Cognitive Impairment and Gait Disturbance
Neurol 99:997-1003, Chaity,D.K.,et al, 2022
Thymoma and Autoimmune Encephalitis
Neuroimmunol Neuroinflamm 8:e1053, Guasp,M.,et al, 2021
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder
Neurol 96:e811-e830, Burt, R.K.,et al, 2021
Sequential Bilateral Vision Loss in a Woman with Scalp Tenderness and Jaw Claudication
JAMA Neurol 78:878-879, Kaufman, A.R.,et al, 2021
Clinicopathologic Conference, Vascular Ehlers-Danlos Syndrome
NEJM 385:1317-1325, Case 30-2021, 2021
Hematopoietic Stem - and Progenitor-Cell Gene Therapy for Hurler Syndrome
NEJM 385:1929-1940, Gentner, B.,et al, 2021
Progressive Multifocal Leukoencephalopathy in a Patient with Primary Amyloid Light-Chain Amyloidosis
Clin Neurol Neurosurg 192:doi105709, Katsuse, K.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions
Neurol 95:e3153-e3159, Russ, J.B.,et al, 2020
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020
Spasms and Myoclonus in a Young Woman with Hashimoto Thyroiditis
JAMA Neurol 77:650-651, Shen, D.,et al, 2020
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease
NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020
Liver Transplantation as a Rescue Therapy for Severe Neurologic Forms of Wilson Disease
Neurol 94:e2189-e2202, Poujois, A.,et al, 2020
CASPR2 Autoimmunity in Children Expanding to Mild Encephalopathy with Hypertension
Neurol 94:e2290-e2301,953, Syrbe, S.,et al, 2020